Redeye endorses the news that Egetis has finalized a directed issue of some SEK300m to new and existing shareholders, including to international healthcare specialists.
ANNONS
Redeye endorses the news that Egetis has finalized a directed issue of some SEK300m to new and existing shareholders, including to international healthcare specialists.